thiazoles has been researched along with losartan in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Aki, Y; He, H; Iwao, H; Kiyomoto, H; Masumura, H; Nishiyama, A; Tamaki, T; Yamamoto, A | 1 |
| Duan, J; Fernandes, BH; Jaramillo, J; Jung, GL; Mathis, D; McLeod, AL | 1 |
| Chen, R; Garnovskaya, MN; Huang, C; Iijima, Y; Mukhin, YV; Paul, RV; Raymond, JR; Thielen, TE; Ullian, ME | 1 |
| Avery, MA; Benson, SC; Chittiboyina, A; Desai, P; Ho, CI; Kurtz, TW; Pershadsingh, HA; Pravenec, M; Qi, N; Wang, J | 1 |
| Bomalaski, JS; Clark, MA | 1 |
| Cheng, YQ; Jia, Y; Li, XH; Liu, Y; Wang, XQ; Zhang, HG; Zhou, JZ | 1 |
| Ji, Z; Qiu, G | 1 |
| Cserni, BG; Cserni, G; Csont, T; Dinh, H; Farkas, K; Földesi, I; Freiwan, M; Horváth, P; Kovács, F; Kovács, MG; Kovács, ZZA; Kővári, B; Kriston, A; Márványkövi, FM; Sárközy, M; Siska, A; Szűcs, G | 1 |
| Cserni, G; Csont, T; Dinh, H; Dux, L; Földesi, I; Freiwan, M; Horváth, P; Kovács, F; Kovács, MG; Kovács, ZZA; Kriston, A; Losonczi, R; Sárközy, M; Siska, A; Szűcs, G | 1 |
1 review(s) available for thiazoles and losartan
| Article | Year |
|---|---|
Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.
Topics: Allopurinol; Amlodipine; Clinical Trials as Topic; Enzyme Inhibitors; Febuxostat; Gout; Humans; Hyperuricemia; Losartan; Pyrazoles; Thiazoles; Treatment Outcome; Urate Oxidase; Uric Acid; Xanthine Oxidase | 2004 |
8 other study(ies) available for thiazoles and losartan
| Article | Year |
|---|---|
Effects of semotiadil fumarate (SD-3211) on renal hemodynamics and function in dogs.
Topics: Analysis of Variance; Animals; Biphenyl Compounds; Calcium Channel Blockers; Diuresis; Dogs; Electrolytes; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Thiazoles | 1992 |
Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig.
Topics: Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Captopril; Guinea Pigs; Imidazoles; Losartan; Male; Nephrectomy; Pyridines; Renin; Renin-Angiotensin System; Tetrazoles; Thiazoles | 1995 |
A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biological Transport; Calcium; Cell Nucleus; CHO Cells; Cricetinae; Fluorescent Dyes; Genes, Reporter; Green Fluorescent Proteins; Indicators and Reagents; Iodine Radioisotopes; Losartan; Luminescent Proteins; Microscopy, Confocal; Quinolinium Compounds; Radioligand Assay; Rats; Receptors, Angiotensin; Recombinant Fusion Proteins; Thiazoles | 2000 |
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
Topics: Adipocytes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Cell Differentiation; Cells, Cultured; Chlorocebus aethiops; Drug Evaluation, Preclinical; Gene Expression Regulation; Imidazoles; Insulin; Irbesartan; Losartan; Male; Mice; Models, Molecular; Myoblasts; Protein Conformation; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Structure-Activity Relationship; Telmisartan; Tetrazoles; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Triglycerides; Valine; Valsartan; Weight Gain | 2004 |
Gαq-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates proliferation of vascular smooth muscle cells and vascular remodeling in spontaneously hypertensive rats.
Topics: 3T3 Cells; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Blood Pressure Determination; Calcium; Cardiotonic Agents; Cell Culture Techniques; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; GTP-Binding Protein alpha Subunits, Gq-G11; Hypertension; Hypertrophy; Losartan; Male; Mice; Molecular Targeted Therapy; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peptides; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Tetrazolium Salts; Thiazoles; Type C Phospholipases; Vasoconstrictor Agents | 2011 |
AngII-induced glomerular mesangial cell proliferation inhibited by losartan via changes in intracellular calcium ion concentration.
Topics: Angiotensin II; Blotting, Western; Calcium; Cations, Divalent; Cell Line; Cell Proliferation; Cytoplasm; Gene Expression Profiling; Humans; Losartan; Mesangial Cells; Microscopy, Confocal; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Tetrazolium Salts; Thiazoles; TRPC Cation Channels; TRPC6 Cation Channel; Trypan Blue | 2014 |
Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Antihypertensive Agents; Cardiomyopathies; Losartan; Male; Nephrectomy; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Thiazoles; Uremia | 2021 |
Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model.
Topics: Acetanilides; Animals; Cardiomyopathies; Cardiotoxicity; Doxorubicin; Losartan; Male; Rats; Rats, Wistar; Thiazoles | 2022 |